Epigenetic Mechanisms Underlying the Pathogenesis of Neurogenetic Diseases

被引:0
|
作者
Irfan A. Qureshi
Mark F. Mehler
机构
[1] Albert Einstein College of Medicine,Roslyn and Leslie Goldstein Laboratory for Stem Cell Biology and Regenerative Medicine
[2] Albert Einstein College of Medicine,Institute for Brain Disorders and Neural Regeneration
[3] Albert Einstein College of Medicine,Department of Neurology
[4] Albert Einstein College of Medicine,Department of Neuroscience
[5] Albert Einstein College of Medicine,Department of Psychiatry and Behavioral Sciences
[6] Albert Einstein College of Medicine,Rose F. Kennedy Center for Research on Intellectual and Developmental Disabilities
[7] Albert Einstein College of Medicine,Einstein Cancer Center
[8] Albert Einstein College of Medicine,Ruth L. and David S. Gottesman Stem Cell Institute
[9] Albert Einstein College of Medicine,Center for Epigenomics
[10] Albert Einstein College of Medicine,Institute for Aging Research
来源
Neurotherapeutics | 2014年 / 11卷
关键词
Chromatin; DNA methylation; Epigenetic; Epigenome; Histone; Noncoding RNA;
D O I
暂无
中图分类号
学科分类号
摘要
There have been considerable advances in uncovering the complex genetic mechanisms that underlie nervous system disease pathogenesis, particularly with the advent of exome and whole genome sequencing techniques. The emerging field of epigenetics is also providing further insights into these mechanisms. Here, we discuss our understanding of the interplay that exists between genetic and epigenetic mechanisms in these disorders, highlighting the nascent field of epigenetic epidemiology—which focuses on analyzing relationships between the epigenome and environmental exposures, development and aging, other health-related phenotypes, and disease states—and next-generation research tools (i.e., those leveraging synthetic and chemical biology and optogenetics) for examining precisely how epigenetic modifications at specific genomic sites affect disease processes.
引用
收藏
页码:708 / 720
页数:12
相关论文
共 50 条
  • [1] Epigenetic Mechanisms Underlying the Pathogenesis of Neurogenetic Diseases
    Qureshi, Irfan A.
    Mehler, Mark F.
    NEUROTHERAPEUTICS, 2014, 11 (04) : 708 - 720
  • [2] Epigenetic Mechanisms Underlying COVID-19 Pathogenesis
    Kaneko, Syuzo
    Takasawa, Ken
    Asada, Ken
    Shinkai, Norio
    Bolatkan, Amina
    Yamada, Masayoshi
    Takahashi, Satoshi
    Machino, Hidenori
    Kobayashi, Kazuma
    Komatsu, Masaaki
    Hamamoto, Ryuji
    BIOMEDICINES, 2021, 9 (09)
  • [3] Neurogenetic mechanisms underlying cognition and temperament
    Strobel, Alexander
    EUROPEAN JOURNAL OF PERSONALITY, 2007, 21 (05) : 630 - 632
  • [4] Epigenetic Mechanisms Underlying Sex Differences in Neurodegenerative Diseases
    Stoccoro, Andrea
    BIOLOGY-BASEL, 2025, 14 (01):
  • [5] Mechanisms underlying phenotypic variation in neurogenetic disorders
    Jean-Marc Burgunder
    Nature Reviews Neurology, 2023, 19 : 363 - 370
  • [6] Mechanisms underlying phenotypic variation in neurogenetic disorders
    Burgunder, Jean-Marc
    NATURE REVIEWS NEUROLOGY, 2023, 19 (06) : 363 - 370
  • [7] Editorial: Epigenetic and genetic mechanisms underlying cardiovascular diseases and neurodevelopmental disorders
    Zhang, Peng
    Gou, Lingshan
    Murugan, Dharmani Devi
    Zhang, Hongsong
    FRONTIERS IN GENETICS, 2024, 15
  • [8] The epigenetic mechanisms underlying gamete origin of adult-onset diseases
    Ding, Guolian
    Chen, Bin
    McCarrey, John R.
    Huang, Hefeng
    SCIENCE BULLETIN, 2022, 67 (17) : 1724 - 1727
  • [9] Epigenetic Mechanisms Underlying the Pathogenesis of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Cheng, J. X.
    Anastasi, J.
    Shen, J. Q.
    Watanabe, K.
    Grimley, E.
    Kleinbrink, E.
    Knibbs, R.
    Roulston, D.
    Vardiman, J. W.
    MODERN PATHOLOGY, 2012, 25 : 329A - 330A
  • [10] Epigenetic Mechanisms Underlying the Pathogenesis of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Cheng, J. X.
    Anastasi, J.
    Shen, J. Q.
    Watanabe, K.
    Grimley, E.
    Kleinbrink, E.
    Knibbs, R.
    Roulston, D.
    Vardiman, J. W.
    LABORATORY INVESTIGATION, 2012, 92 : 329A - 330A